https://dengyuemed.com/cancers-nemesis-5-fluorouracil-injection-your-guide-to-cancer-treatment-options/2025-02-20T16:22:56+08:00https://dengyuemed.com/corydal-approved-for-locally-advanced-cervical-cancer-treatment-indication-in-china/2024-12-13T16:10:15+08:00https://dengyuemed.com/methylene-blue-enteric-delayed-release-tablets/2024-12-13T16:10:29+08:00https://dengyuemed.com/how-to-take-apatinib-mesylate-tablets/2024-12-16T14:59:15+08:00https://dengyuemed.com/use-thymopeptide-enteric-coated-capsules/2024-12-30T10:06:35+08:00https://dengyuemed.com/a-complete-guide-to-azathioprine-tablets/2024-12-30T10:09:56+08:00https://dengyuemed.com/ubenimex-capsules-uses-side-effects-cost/2024-12-30T10:05:09+08:00https://dengyuemed.com/bicalutamide-50-mg-for-prostate-cancer/2025-01-16T11:37:31+08:00https://dengyuemed.com/how-to-use-imatinib-mesylate/2024-12-20T16:06:32+08:00https://dengyuemed.com/how-to-use-agalsidase-alfa/2024-12-24T15:23:32+08:00https://dengyuemed.com/nusinersen-sodium-injection-for-spinal-muscular-atrophy/2025-01-02T10:38:42+08:00https://dengyuemed.com/risdiplam-leading-the-way-in-spinal-muscular-atrophy/2024-12-30T15:53:00+08:00https://dengyuemed.com/injectable-alglucosidase-alfa-the-key-for-pompe-disease/2024-12-30T16:48:28+08:00https://dengyuemed.com/pitolisant-hydrochloride/2024-12-30T15:22:37+08:00https://dengyuemed.com/eculizumab-injection-on-rare-blood-disease-treatment/2025-01-03T18:22:07+08:00https://dengyuemed.com/siltuximab-for-injection-new-chapter-in-castlemans-disease/2025-01-04T14:32:04+08:00https://dengyuemed.com/spesolimab-injection/2025-01-04T18:00:17+08:00https://dengyuemed.com/ozamode-hydrochloride-capsules/2025-01-04T14:28:24+08:00https://dengyuemed.com/sirolimus-gel/2025-01-07T15:35:09+08:00https://dengyuemed.com/enspryng-satralizumab/2025-01-08T16:19:59+08:00https://dengyuemed.com/nitisinone-capsules/2025-01-09T11:44:04+08:00https://dengyuemed.com/crovalimab-aplastic-anemia-treatment/2025-01-09T17:30:52+08:00https://dengyuemed.com/sodium-phenylbutyrate-is-used-in-urea-cycle-disorders/2025-03-10T09:34:37+08:00https://dengyuemed.com/diazoxide-is-used-to-treat-hypoglycemia-caused-by-a-number-of-specific-reasons/2025-01-10T17:28:10+08:00https://dengyuemed.com/trientine-hydrochloride-tablets-are-used-to-treat-wilsons-disease/2025-01-14T09:32:15+08:00https://dengyuemed.com/disitamab-vedotin-of-injection/2025-02-18T16:25:25+08:00https://dengyuemed.com/polyethylene-glycol-recombinant-human-somatropin-injection/2025-01-17T10:47:14+08:00https://dengyuemed.com/avapritinib-tablets/2025-01-17T14:35:25+08:00https://dengyuemed.com/ubenimex-capsules/2025-01-14T09:53:41+08:00https://dengyuemed.com/capecitabine-benefits-risks-and-precautions/2025-01-17T15:15:33+08:00https://dengyuemed.com/tetrabenazine-tablets/2025-01-18T16:56:12+08:00https://dengyuemed.com/burosumab-for-x-linked-hypophosphatemic-rickets/2025-01-18T17:11:50+08:00https://dengyuemed.com/hydroxyurea/2025-01-18T17:28:41+08:00https://dengyuemed.com/idursulfase-treat-mucopolysaccharidosis/2025-01-20T17:50:00+08:00https://dengyuemed.com/megestrol-acetate-for-breast-cancer/2025-01-20T14:54:51+08:00https://dengyuemed.com/elosulfase-alpha/2025-01-20T15:38:26+08:00https://dengyuemed.com/tegafur-capsules/2025-01-20T16:15:22+08:00https://dengyuemed.com/carglumic-acid/2025-01-20T16:04:02+08:00https://dengyuemed.com/urea-ointment/2025-01-20T16:24:35+08:00https://dengyuemed.com/teduglutide-treatment-short-bowel-syndrome/2025-01-20T16:34:06+08:00https://dengyuemed.com/susoctocog-alfa-acquired-hemophilia-treatment/2025-01-20T16:53:24+08:00https://dengyuemed.com/tunlametinib-targeted-in-melanoma-therapy/2025-01-20T17:04:48+08:00https://dengyuemed.com/etoposide-soft-capsules/2025-01-20T17:29:54+08:00https://dengyuemed.com/somatuline-neuroendocrine-tumors/2025-01-21T09:57:20+08:00https://dengyuemed.com/cefpirome-sulfate/2025-01-21T15:36:19+08:00https://dengyuemed.com/romiplostim-the-savior-of-platelet-problems/2025-01-21T15:56:07+08:00https://dengyuemed.com/cenegermin-ophthalmic-regenerative-medicine/2025-01-21T16:18:52+08:00https://dengyuemed.com/toremifene-citrate/2025-01-21T16:43:34+08:00https://dengyuemed.com/calcitriol-soft-capsules-for-bone-health/2025-01-21T16:31:58+08:00https://dengyuemed.com/anastrozole-tablets/2025-01-21T17:07:41+08:00https://dengyuemed.com/maralixibat-treating-alagille-syndrome/2025-01-22T14:19:01+08:00https://dengyuemed.com/sapropterin-improves-symptoms-of-phenylketonuria/2025-01-22T14:39:18+08:00https://dengyuemed.com/thymopentin-for-injection/2025-01-22T16:44:37+08:00https://dengyuemed.com/emapalumab/2025-03-04T16:38:25+08:00https://dengyuemed.com/carmofur/2025-01-22T16:13:03+08:00https://dengyuemed.com/sorafenib-tosylate/2025-01-22T16:26:04+08:00https://dengyuemed.com/dantrolene-treatment-of-malignant-hyperthermia/2025-01-23T09:51:54+08:00https://dengyuemed.com/dinutuximab-for-neuroblastoma/2025-01-23T11:33:28+08:00https://dengyuemed.com/compound-cyclophosphamide/2025-01-23T11:54:45+08:00https://dengyuemed.com/salcatonin-nasal-spray/2025-01-23T14:27:30+08:00https://dengyuemed.com/recombinant-human-thrombopoietin-injection/2025-01-23T14:45:12+08:00https://dengyuemed.com/bozitinib-the-glioblastoma-treatment-track/2025-01-23T15:03:16+08:00https://dengyuemed.com/iptacopan-treat-paroxysmal-nocturnal-hemoglobinuria/2025-01-23T15:25:17+08:00https://dengyuemed.com/gemcitabine/2025-01-23T15:38:09+08:00https://dengyuemed.com/asfotase-alfa-treat-hypophosphatemia/2025-01-23T17:29:11+08:00https://dengyuemed.com/efgartigimod-alfa-treatment-myasthenia-gravis/2025-01-23T16:26:32+08:00https://dengyuemed.com/caffeic-acid-tablets/2025-05-27T09:34:21+08:00https://dengyuemed.com/vigabatrin-treatment-of-infantile-spasms/2025-01-24T10:39:38+08:00https://dengyuemed.com/eliglustat-treatment-of-type-1-gaucher-disease/2025-01-24T10:55:09+08:00https://dengyuemed.com/cladribine/2025-01-24T11:33:55+08:00https://dengyuemed.com/selumetinib-assist-neurofibropathy-type-i/2025-02-19T14:38:56+08:00https://dengyuemed.com/bleomycin-a5-hydrochloride/2025-01-24T11:41:17+08:00https://dengyuemed.com/meisoindigo-treatment-chronic-myeloid-leukemia/2025-01-24T11:51:45+08:00https://dengyuemed.com/ifosfamide-fight-against-cancer/2025-01-24T15:47:11+08:00https://dengyuemed.com/tretinoin-tablets-latest-news-and-application/2025-02-09T11:08:55+08:00https://dengyuemed.com/vindesine-sulfate-injection/2025-02-19T14:40:53+08:00https://dengyuemed.com/hydroxylcamptothecine-injection-tumor-treatment/2025-02-10T14:55:30+08:00https://dengyuemed.com/medroxyprogesterone-acetate-for-cancer-patients/2025-02-14T14:43:13+08:00https://dengyuemed.com/transfer-factor/2025-02-10T14:27:38+08:00https://dengyuemed.com/methotrexate-cancer-immune-disease-treatment/2025-02-14T15:03:16+08:00https://dengyuemed.com/zoledronic-acid-injection-combats-bone-disease/2025-02-16T14:35:55+08:00https://dengyuemed.com/new-hope-in-sight-chloroxoquinoline-capsules/2025-02-16T10:00:21+08:00https://dengyuemed.com/sunitinib-malate-anti-cancer-tool/2025-02-17T11:46:10+08:00https://dengyuemed.com/lentinus-edodes-mycelia-polysacharide/2025-02-19T14:35:24+08:00https://dengyuemed.com/fludarabine-treatment-of-blood-diseases/2025-02-19T11:31:19+08:00https://dengyuemed.com/the-wonders-of-imatinib-mesylate-tablets/2025-02-17T11:30:35+08:00https://dengyuemed.com/nimustine-hydrochloride/2025-02-19T14:26:14+08:00https://dengyuemed.com/zolbetuximab-clzb-for-injection/2025-02-22T17:13:13+08:00https://dengyuemed.com/lunsumio-in-b-cell-lymphoma-treat/2025-02-25T09:28:52+08:00https://dengyuemed.com/what-is-loncastuximab-tesirine/2025-02-25T14:26:27+08:00https://dengyuemed.com/janagliflozin-mechanism-of-action/2025-02-27T14:10:44+08:00https://dengyuemed.com/sacituzumab-tirumotecan-in-breast-cancer/2025-02-26T09:30:30+08:00https://dengyuemed.com/mirvetuximab-soravtansine-gynx-injection/2025-02-26T15:02:27+08:00https://dengyuemed.com/what-is-the-new-drug-for-lung-cancer-in-2024/2025-02-25T16:56:45+08:00https://dengyuemed.com/rilonacept-injection-auto-inflammatory-disorder/2025-02-26T15:39:16+08:00https://dengyuemed.com/ongericimab-injection-approved-for-use-in-china/2025-02-27T14:36:12+08:00https://dengyuemed.com/iparomlimab-and-tuvonralimab-injection/2025-02-27T14:29:43+08:00https://dengyuemed.com/mavacamten-capsules-mechanism-action-side-effects/2025-02-27T15:58:26+08:00https://dengyuemed.com/treatment-turoctocog-alfa-pegol/2025-02-27T17:57:59+08:00https://dengyuemed.com/carvykti-offers-for-multiple-myeloma-patients/2025-03-03T14:54:28+08:00https://dengyuemed.com/padcev-metastatic-urothelial-cancer/2025-03-03T15:23:36+08:00https://dengyuemed.com/new-medication-for-lung-cancer/2025-03-04T10:32:56+08:00https://dengyuemed.com/benralizumab-injection/2025-03-04T15:05:12+08:00https://dengyuemed.com/nuwiq-hemophilia-low-inhibitory-factor/2025-03-04T15:35:40+08:00https://dengyuemed.com/vonvendi-approved-by-fda/2025-03-07T10:03:54+08:00https://dengyuemed.com/bimzelx-approved-for-psoriatic-arthritis/2025-03-05T16:09:08+08:00https://dengyuemed.com/besremi-ropeginterferon-alfa-2b/2025-03-06T10:34:46+08:00https://dengyuemed.com/enlonstobart-injection/2025-03-06T10:58:27+08:00https://dengyuemed.com/tecvayli-treats-multiple-myeloma/2025-03-07T10:27:39+08:00https://dengyuemed.com/ivonescimab-akeso-showed-significant/2025-03-07T11:01:27+08:00https://dengyuemed.com/what-you-need-to-know-about-sulbactam-durlobactam/2025-03-06T15:59:46+08:00https://dengyuemed.com/zevorcabtagene-autoleucel/2025-03-19T10:55:19+08:00https://dengyuemed.com/european-medicines-agency-reassesses-leqembi/2025-03-12T12:04:09+08:00https://dengyuemed.com/taletrectinib-adipate-capsules/2025-03-19T10:53:45+08:00https://dengyuemed.com/uric-acid-lowering-drug-urece-tablet-offers/2025-03-14T11:39:11+08:00https://dengyuemed.com/zepzelca-small-cell-lung-cancer-treatment/2025-03-14T11:52:23+08:00https://dengyuemed.com/pretomanid-200-mg-receives-ema-recommendation/2025-03-18T10:12:34+08:00https://dengyuemed.com/xadago-is-leading-hope-for-parkinsons-disease/2025-03-18T10:30:02+08:00https://dengyuemed.com/garsorasib-company-with-kras-g12c-mutation/2025-03-20T11:48:34+08:00https://dengyuemed.com/welireg-a-breakthrough-in-cancer-treatment/2025-03-18T10:42:36+08:00https://dengyuemed.com/tavneos-offers-with-anca-associated-vasculitis/2025-03-20T14:10:13+08:00https://dengyuemed.com/talzenna-bringing-targeted-treatment/2025-03-20T14:59:43+08:00https://dengyuemed.com/new-hepatitis-b-treatment-pradefovir-mesylate/2025-03-25T10:14:49+08:00https://dengyuemed.com/jaypirca-offers-new-hope-for-tumors/2025-03-25T10:29:27+08:00https://dengyuemed.com/avacincaptad-pegol-mechanism-side-effects/2025-03-17T14:32:53+08:00https://dengyuemed.com/qalsody-a-milestone-in-the-of-acromegaly/2025-03-25T10:44:34+08:00https://dengyuemed.com/isturisa-hope-for-cushings-syndrome-treatment/2025-04-08T09:40:46+08:00https://dengyuemed.com/krazati-adagrasib-a-comprehensive-guide/2025-06-27T10:32:13+08:00https://dengyuemed.com/iclusig-breakthroughs-in-resistant-leukemia/2025-03-26T10:06:26+08:00https://dengyuemed.com/fulzerasib-tablets-new-era-in-targeted-cancer/2025-03-26T10:15:12+08:00https://dengyuemed.com/aclidinium-bromide-drug-a-promising-for-copd/2025-03-26T10:25:07+08:00https://dengyuemed.com/cidofovir-injection-uses-dosage-side-effects/2025-03-20T15:18:43+08:00https://dengyuemed.com/astellas-pharmaceuticals-group/2025-03-26T10:55:56+08:00https://dengyuemed.com/agamree-vamorolone-uses-benefits-and-safety/2025-03-20T17:34:49+08:00https://dengyuemed.com/rezivertinib-mesylate-capsules-hope-for-nsclc/2025-04-09T14:25:55+08:00https://dengyuemed.com/tabrecta-non-small-cell-lung-cancer/2025-04-09T11:15:07+08:00https://dengyuemed.com/parsabiv-etelcalcetide-for-the-shpt/2025-04-08T14:51:34+08:00https://dengyuemed.com/retevmo-selpercatinib-achieves-positive/2025-04-08T09:45:57+08:00https://dengyuemed.com/alkindi-hydrocortisone-a-comprehensive-guide/2025-03-24T10:44:48+08:00https://dengyuemed.com/vutrisiran-injection-a-comprehensive-guide/2025-06-27T10:23:47+08:00https://dengyuemed.com/betagrin-developes-new-energy-solution/2025-03-28T11:49:43+08:00https://dengyuemed.com/golidocitinib-capsules-jak1-inhibitors/2025-03-28T10:42:55+08:00https://dengyuemed.com/how-to-use-aspaveli-pegcetacoplan/2025-03-25T16:24:55+08:00https://dengyuemed.com/lorviqua-lorlatinib-non-small-cell-lung-cancer/2025-03-28T11:54:06+08:00https://dengyuemed.com/how-to-use-augtyro-repotrectinib-capsules/2025-04-07T10:21:08+08:00https://dengyuemed.com/talvey-talquetamab-tgvs-multiple-myeloma/2025-04-08T09:21:35+08:00https://dengyuemed.com/sogroya-somapacitan-growth-hormone-therapy/2025-06-03T11:08:49+08:00https://dengyuemed.com/rytelo-imestatnew-hope-for-mds-patients/2025-04-17T16:37:44+08:00https://dengyuemed.com/rylaze-receives-acute-lymphoblastic-leukaemia/2025-04-19T14:48:24+08:00https://dengyuemed.com/rezolsta-for-adolescent-hiv-patient-to-further/2025-04-19T17:34:59+08:00https://dengyuemed.com/revuforj-new-hope-for-leukaemia/2025-04-17T09:54:46+08:00https://dengyuemed.com/actimmune-severe-osteopetrosis-in-pediatric/2025-04-07T17:16:01+08:00https://dengyuemed.com/brineura-prolong-quality-of-life-in-cln2/2025-04-08T17:21:14+08:00https://dengyuemed.com/folotyn-receives-fda-approval-global-update/2025-04-09T17:21:21+08:00https://dengyuemed.com/lumizyme-a-light-for-rare-disease-treatment/2025-04-10T17:13:47+08:00https://dengyuemed.com/luxturnahope-for-with-hereditary-vision-loss/2025-04-11T16:39:37+08:00https://dengyuemed.com/myalepta-hope-for-patients-with-lipodystrophy/2025-04-12T16:15:57+08:00https://dengyuemed.com/ravicti-urea-cycle-disorders/2025-04-16T10:02:00+08:00https://dengyuemed.com/soliris-in-the-treatment-of-rare-diseases/2025-04-15T16:54:30+08:00https://dengyuemed.com/novartis-zolgensma-gene-therapy-significant/2025-04-16T16:24:04+08:00https://dengyuemed.com/quviviq-new-ray-of-hope-in-insomnia-treatment/2025-04-17T10:08:53+08:00https://dengyuemed.com/qelbree-that-brings-hope-for-specific-needs/2025-04-17T10:17:48+08:00https://dengyuemed.com/ontozry-approved-in-eu-for-refractory-epilepsy/2025-04-21T10:01:03+08:00https://dengyuemed.com/ojjaara-emerges-as-breakthrough-treatment/2025-04-18T09:23:38+08:00https://dengyuemed.com/ogsiveo-emerges-as-first-targeted-therapy/2025-04-26T15:11:56+08:00https://dengyuemed.com/nebido-breakthrough-in-global-mens-health/2025-04-21T14:48:19+08:00https://dengyuemed.com/nurtec-odtdual-action-oral-dissolving-tablet/2025-04-22T09:34:37+08:00https://dengyuemed.com/minjuvi-approved-for-marketing-in-mexico/2025-04-23T10:04:55+08:00https://dengyuemed.com/lytgobi-for-treatment-of-intrahepatic/2025-04-23T10:11:15+08:00https://dengyuemed.com/lybalvi-offers-safer-option-for-patients/2025-04-25T10:45:38+08:00https://dengyuemed.com/oral-lupus-nephritis-drug-lupkynis-voclosporin/2025-04-25T10:57:12+08:00https://dengyuemed.com/kineret-anakinra-for-the-treatment/2025-04-25T14:16:35+08:00https://dengyuemed.com/kisunla-hope-in-early-alzheimers-treatment/2025-05-08T09:36:49+08:00https://dengyuemed.com/jemperli-gets-to-take-its-place-in-cancer/2025-04-26T10:19:14+08:00https://dengyuemed.com/endocrinology-portfolio-with-increlex/2025-05-06T09:44:52+08:00https://dengyuemed.com/impavido-in-the-fight-against-leishmaniasis/2025-06-03T11:08:35+08:00https://dengyuemed.com/imdelltra-small-cell-lung-cancer/2025-06-03T11:08:22+08:00https://dengyuemed.com/hympavzi-use-in-treating-hemophilia-symptoms/2025-06-03T11:08:13+08:00https://dengyuemed.com/fampyra-enhancing-mobility-multiple-sclerosis/2025-06-03T11:08:01+08:00https://dengyuemed.com/antizol-a-critical-antidote-in-toxicology/2025-06-03T11:07:34+08:00https://dengyuemed.com/fetroja-a-breakthrough-in-combating-multidrug/2025-06-03T11:07:18+08:00https://dengyuemed.com/elrexfio-hope-for-refractory-multiple-myeloma/2025-06-03T11:07:06+08:00https://dengyuemed.com/dupixents-expanding-therapeutic-reach/2025-06-03T11:06:55+08:00https://dengyuemed.com/calcort-a-global-perspective-on-its-role/2025-06-03T11:06:43+08:00https://dengyuemed.com/cystadane-milestone-in-treating-homocystinuria/2025-06-03T11:06:24+08:00https://dengyuemed.com/cinryze-navigating-challenges-in-hereditary/2025-06-03T11:06:08+08:00https://dengyuemed.com/cablivis-2025-outlook-advancements/2025-06-03T10:42:08+08:00https://dengyuemed.com/braftovi-shows-promising-survival-benefits/2025-04-30T15:55:32+08:00https://dengyuemed.com/tryngolzaolezarsen-approved-for-fcs/2025-04-28T17:38:22+08:00https://dengyuemed.com/fda-approves-alhemo-breakthrough-in-hemophilia/2025-04-29T14:48:17+08:00https://dengyuemed.com/beovu-for-diabetic-macular-edema-a-new-era/2025-06-03T11:05:43+08:00https://dengyuemed.com/ensacove-in-non-small-cell-lung-cancer/2025-04-30T14:47:40+08:00https://dengyuemed.com/crenessity-in-pediatric-congenital-adrenal-hyperplasia/2025-04-30T15:20:59+08:00https://dengyuemed.com/therapeutics-achieves-milestone-with-unloxcyt/2025-05-07T10:30:38+08:00https://dengyuemed.com/bizengri-breakthrough-targeted-therapy-for-nrg/2025-05-09T11:21:51+08:00https://dengyuemed.com/attruby-attr-cm-treatment-clinical-success/2025-05-09T11:22:53+08:00https://dengyuemed.com/ziihera-for-her2-positive-biliary-tract-cancer/2025-05-09T11:24:25+08:00https://dengyuemed.com/orlynvah-offers-hope-amid-rising-antibiotic/2025-05-09T11:25:19+08:00https://dengyuemed.com/itovebi-new-targeted-therapy-for-breast-cancer/2025-05-13T14:07:27+08:00https://dengyuemed.com/flyrcado-a-breakthrough-in-cardiac-pet-imaging/2025-05-13T14:35:53+08:00https://dengyuemed.com/cobenfy-a-frontier-in-schizophrenia-treatment/2025-05-14T10:10:55+08:00https://dengyuemed.com/why-is-auvelity-the-future-of-depression-care/2025-05-14T13:57:04+08:00https://dengyuemed.com/aqneursa-niemann-pick-disease-type-c-patients/2025-05-22T10:12:37+08:00https://dengyuemed.com/is-briumvi-the-breakthrough-treatment-for-relapsing-ms/2025-05-16T10:17:23+08:00https://dengyuemed.com/miplyffa-approval-to-fill-npc-treatment-gap/2025-05-22T10:16:48+08:00https://dengyuemed.com/akynzeo-capsule-preventing-nausea-and-vomiting/2025-05-19T14:02:40+08:00https://dengyuemed.com/lazcluze-treatment-non-small-cell-lung-cancer/2025-05-22T10:19:16+08:00https://dengyuemed.com/6-must-know-facts-about-briviact/2025-05-19T16:59:09+08:00https://dengyuemed.com/do-you-know-about-niktimvo-healing-properties/2025-05-22T10:59:42+08:00https://dengyuemed.com/alyftrek-drug-a-new-era-in-cystic-fibrosis-treatment/2025-05-22T11:44:40+08:00https://dengyuemed.com/datroway-reduction-in-the-risk-of-death/2025-05-21T10:09:28+08:00https://dengyuemed.com/mirdametinib-hope-for-inoperable-nf1/2025-05-21T11:22:15+08:00https://dengyuemed.com/is-grafapex-worth-it-in-2025-pros-cons/2025-05-21T14:37:03+08:00https://dengyuemed.com/will-vimseltinib-cure-tgct/2025-05-22T15:58:36+08:00https://dengyuemed.com/is-blujepa-right-for-you-fda-treatment/2025-05-23T09:22:31+08:00https://dengyuemed.com/is-letibotulinumtoxina-wlbg-glabellar-lines/2025-05-23T16:02:43+08:00https://dengyuemed.com/fda-approved-qfitlia-discover-a-novel-treatment/2025-05-23T15:09:05+08:00https://dengyuemed.com/tislelizumab-jsgr-offers-a-chance-for-escc/2025-05-26T13:57:02+08:00https://dengyuemed.com/is-rezdiffra-the-key-to-unlocking-better-nash-outcomes/2025-05-26T14:09:18+08:00https://dengyuemed.com/worried-about-skin-cancer-could-zelsuvmi-be-the-answer/2025-05-27T13:43:04+08:00https://dengyuemed.com/aprocitentan-challenges-is-it-time-to-try-different/2025-05-28T10:17:52+08:00https://dengyuemed.com/exblifep-a-novel-antibiotic/2025-05-28T14:36:32+08:00https://dengyuemed.com/sotatercept-csrk-the-breakthrough-pah-needs/2025-05-28T15:01:16+08:00https://dengyuemed.com/duvyzat-a-new-hope-for-dmd/2025-09-25T09:58:47+08:00https://dengyuemed.com/ceftobiprole-medocaril-sodium-therapy/2025-05-29T13:59:56+08:00https://dengyuemed.com/nogapendekin-alfa-inbakicept-pmln-bladder/2025-05-30T14:31:52+08:00https://dengyuemed.com/is-tovorafenib-the-missing-link-for-nsclc/2025-05-30T14:32:51+08:00https://dengyuemed.com/mavorixafor-improve-life-with-plgg/2025-05-30T16:40:11+08:00https://dengyuemed.com/is-hepatitis-c-curable-breaking-down-the-myths/2025-06-06T11:31:46+08:00https://dengyuemed.com/could-you-have-copd-without-knowing-it/2025-06-06T16:27:35+08:00https://dengyuemed.com/how-to-catch-ovarian-cancer-early/2025-06-13T17:04:29+08:00https://dengyuemed.com/can-we-outsmart-multiple-myelomas-genetic-maze/2025-06-10T16:21:39+08:00https://dengyuemed.com/hemophilia-a-is-a-cure-possible/2025-06-13T16:32:14+08:00https://dengyuemed.com/why-does-chronic-lymphocytic-leukemia-remain-a-silent-threat/2025-06-17T16:19:50+08:00https://dengyuemed.com/is-colorectal-cancer-curable/2025-06-20T16:42:38+08:00https://dengyuemed.com/is-atopic-dermatitis-a-skin-condition/2025-06-20T16:43:57+08:00https://dengyuemed.com/is-diffuse-large-b-cell-lymphoma-unsolved-puzzle/2025-06-24T15:44:31+08:00https://dengyuemed.com/how-to-manage-anaplastic-lymphoma-kinase-alk/2025-06-24T17:38:27+08:00https://dengyuemed.com/why-does-es-sclc-remain-so-deadly/2025-06-26T16:25:43+08:00https://dengyuemed.com/can-you-recover-positive-breast-cancer/2025-06-26T17:11:58+08:00https://dengyuemed.com/what-are-the-5-warning-signs-of-bladder-cancer/2025-07-17T17:33:38+08:00https://dengyuemed.com/molecular-glues-the-next-golden-track-in-drug/2025-06-27T17:33:11+08:00https://dengyuemed.com/anti-vegf-therapy-prepares-for-market-filing/2025-06-27T15:42:31+08:00https://dengyuemed.com/dato-dxd-adc-approved-by-us-fda-for-lung-cancer/2025-06-27T17:35:20+08:00https://dengyuemed.com/is-chronic-hepatitis-c-curable/2025-07-02T09:53:46+08:00https://dengyuemed.com/is-multiple-sclerosis-stealing-your-energy/2025-07-02T15:43:47+08:00https://dengyuemed.com/us-vs-cn-most-expensive-orphan-drug-list-2025/2025-07-10T14:23:56+08:00https://dengyuemed.com/complicated-intra-abdominal-infections/2025-07-04T15:14:29+08:00https://dengyuemed.com/ibr900-cellular-injection-enters-phase-i-trial/2025-07-04T15:27:52+08:00https://dengyuemed.com/innovative-corneal-storage/2025-07-04T17:05:09+08:00https://dengyuemed.com/china-releases-86-rare-diseases/2025-07-11T15:41:31+08:00https://dengyuemed.com/25-human-albumin-injection-approved-in-china/2025-07-18T14:43:31+08:00https://dengyuemed.com/how-to-avoid-getting-thyroid-cancer/2025-07-22T17:16:44+08:00https://dengyuemed.com/how-long-do-antibiotics-take-to-work-a-blog-to-fast-recovery/2025-07-24T15:59:09+08:00https://dengyuemed.com/how-i-knew-i-had-stomach-cancer/2025-12-18T17:45:55+08:00https://dengyuemed.com/what-are-the-top-20-antibiotics-their-mechanisms-and-common-applications/2025-10-13T14:59:45+08:00https://dengyuemed.com/5-effective-ways-to-manage-atopic-dermatitis/2025-09-18T16:14:51+08:00https://dengyuemed.com/chinas-first-arni-class-antihypertensive/2025-09-12T16:36:27+08:00https://dengyuemed.com/brinsupri-receives-fda-approval-for-ncfb/2025-09-05T17:04:18+08:00https://dengyuemed.com/what-are-the-3-warning-signs-of-bladder-cancer/2025-08-21T14:32:11+08:00https://dengyuemed.com/what-causes-thyroid-cancer-in-females/2025-08-28T09:51:22+08:00https://dengyuemed.com/what-are-the-5-warning-signs-of-breast-cance/2025-09-23T16:04:10+08:00https://dengyuemed.com/the-surprising-truth-about-what-triggers-atopic-dermatitis/2025-08-28T09:44:07+08:00https://dengyuemed.com/how-to-check-for-ovarian-cancer-at-home/2025-08-29T15:40:01+08:00https://dengyuemed.com/what-are-the-5-warning-signs-of-cervical-cancer/2025-08-29T15:46:00+08:00https://dengyuemed.com/china-pharmaceutical-surges-ahead-innovative-drugs-launched/2025-09-28T16:05:11+08:00https://dengyuemed.com/a-diabetics-guide-to-preserving-vision/2025-09-05T17:45:50+08:00https://dengyuemed.com/colorectal-cancer-causes-4-key-risk/2025-09-25T16:24:59+08:00https://dengyuemed.com/what-are-the-5-stages-of-bladder-cancer/2025-09-09T16:27:53+08:00https://dengyuemed.com/what-are-the-4-stages-of-copd-symptoms-causes/2025-10-20T15:21:45+08:00https://dengyuemed.com/what-is-the-main-cause-of-kidney-cancer/2025-09-04T17:17:09+08:00https://dengyuemed.com/chinas-tcm-stuns-with-50-exclusive-formulas/2025-10-09T15:28:00+08:00https://dengyuemed.com/zongertinib-tablets-zemetostat-approved/2025-09-05T16:17:24+08:00https://dengyuemed.com/with-affected-by-gastritis-how-to-shield-your-stomach/2025-09-08T14:37:42+08:00https://dengyuemed.com/is-hep-c-curable-5-facts/2025-09-26T17:11:38+08:00https://dengyuemed.com/what-are-the-first-signs-of-lung-cancer/2025-09-09T17:33:28+08:00https://dengyuemed.com/what-to-avoid-when-taking-antibiotics/2025-09-11T10:25:55+08:00https://dengyuemed.com/china-achieves-success-injectable-drugs/2025-09-12T16:55:42+08:00https://dengyuemed.com/seasonal-allergies-acting-up-dont-tought-out/2025-09-16T09:16:05+08:00https://dengyuemed.com/top-5-breakthroughs-in-hematology/2025-10-21T15:47:52+08:00https://dengyuemed.com/5-critical-melanoma-signs-can-know/2025-09-18T14:39:58+08:00https://dengyuemed.com/what-are-the-symptoms-of-kidney-cancer/2025-09-17T17:29:29+08:00https://dengyuemed.com/5-warning-signs-of-kidney-cancer/2025-10-11T14:50:14+08:00https://dengyuemed.com/the-early-whispers-of-soft-tissue-sarcoma/2025-09-18T17:36:48+08:00https://dengyuemed.com/chinas-breakthrough-with-innovative-drugs/2025-10-15T11:44:25+08:00https://dengyuemed.com/new-breakthrough-in-breast-cancer-treatment/2025-09-19T16:34:04+08:00https://dengyuemed.com/world-atopic-dermatitis-day-targeting-minimal-disease/2025-09-19T17:57:14+08:00https://dengyuemed.com/what-are-the-5-warning-signs-of-liver-cancer/2025-10-10T16:15:21+08:00https://dengyuemed.com/how-long-can-someone-live-with-lung-cancer/2025-09-26T11:51:47+08:00https://dengyuemed.com/5-key-types-of-lung-cancer/2025-09-28T16:52:10+08:00https://dengyuemed.com/early-warning-signs-of-ovarian-cancer/2025-09-28T14:56:21+08:00https://dengyuemed.com/aiming-for-a-cure-for-hepatitis-b/2025-09-26T16:11:11+08:00https://dengyuemed.com/bms-five-year-immuno-oncology-legacy-in-china/2025-09-26T17:06:30+08:00https://dengyuemed.com/how-bad-is-lymphoma-cancer-5-powerful-steps/2025-09-29T16:01:36+08:00https://dengyuemed.com/fda-five-innovative-therapies-in-september-2025/2025-09-27T15:45:47+08:00https://dengyuemed.com/prostate-cancer-5-warning-signs-man-should-know/2025-09-29T10:05:13+08:00https://dengyuemed.com/weekly-drug-update-global-new-drug-approvals/2025-09-28T17:02:34+08:00https://dengyuemed.com/is-melanoma-cancer-curable-5-facts/2025-10-16T16:16:06+08:00https://dengyuemed.com/china-launches-thyroid-cancer-awareness-day/2025-10-11T09:37:21+08:00https://dengyuemed.com/fda-approves-five-new-drugs-by-october-2025/2025-10-11T17:25:49+08:00https://dengyuemed.com/new-hope-in-fighting-breast-cancer-understanding-verzenio-abemaciclib/2025-10-16T15:35:01+08:00https://dengyuemed.com/your-hong-kong-pharmaceutical-distributor/2025-11-19T16:49:37+08:00https://dengyuemed.com/chinas-pharmaceutical-breakthroughs-go-global/2025-11-14T11:42:40+08:00https://dengyuemed.com/dual-engines-propel-chinas-innovative-drug-industry/2025-10-16T16:21:19+08:00https://dengyuemed.com/top-10-china-pharma-deals-2025/2025-11-14T11:42:04+08:00https://dengyuemed.com/innovative-drug-development-in-china-global-ambitions/2025-10-17T10:59:48+08:00https://dengyuemed.com/5-powerful-trends-showing-china-innovative-drugs-will-hit-100b-by-2025/2025-10-21T14:59:22+08:00https://dengyuemed.com/can-innovative-drugs-accelerate-overseas-expansion-by-2025/2025-11-14T11:42:27+08:00https://dengyuemed.com/china-pharmaceutical-import-and-export-wholesalers/2025-11-14T15:47:20+08:00https://dengyuemed.com/5-remarkable-achievements-defining-chinas-innovative-pharmaceuticals-sector-in-2025/2025-10-21T15:40:45+08:00https://dengyuemed.com/remarkable-breakthroughs-how-china-innovative-drugs-distributor-network-transformed-global-pharma-growth-in-5-years/2025-10-21T16:39:15+08:00https://dengyuemed.com/navigating-the-global-supply-chain-your-strategic-guide-to-a-china-drug-import-and-export-wholesaler/2025-11-14T16:01:36+08:00https://dengyuemed.com/6-powerful-success-factors-behind-china-innovative-drugs-wholesaler-leading-global-growth/2025-10-21T17:42:33+08:00https://dengyuemed.com/junshis-js207-nsclc-following-fda-clearance-for-phase-ii-iii-trial/2025-10-20T10:06:41+08:00https://dengyuemed.com/__trashed-3/2025-10-30T15:04:56+08:00https://dengyuemed.com/your-hong-kong-pharmaceutical-wholesaler-your-strategic-partner-in-asia/2025-10-22T17:39:46+08:00https://dengyuemed.com/chinese-innovative-drugs-surge-ahead/2025-11-14T11:52:42+08:00https://dengyuemed.com/china-pharmaceutical-wholesaler-the-innovative-bridge/2025-11-20T11:38:43+08:00https://dengyuemed.com/china-pharmaceutical-distributor-benefit/2025-10-27T09:29:44+08:00https://dengyuemed.com/the-china-pharmaceutical-market-trends-future/2025-10-21T16:01:32+08:00https://dengyuemed.com/china-pharmaceutical-imports-reshape-amid-structural-shifts/2025-11-20T11:48:08+08:00https://dengyuemed.com/china-pharmaceutical-supply-chain-the-support-system-behind-66-billion-boom/2025-10-23T15:08:55+08:00https://dengyuemed.com/from-drug-innovation-to-global-distribution-china-pharmaceutical-companies/2025-10-23T15:08:04+08:00https://dengyuemed.com/chinese-drugstore-online-at-the-heart-of-chinas-pharmaceutical-metamorphosis/2025-11-15T17:57:41+08:00https://dengyuemed.com/the-smart-buyers-guide-to-buy-medicine-in-china-quality-value-supply-chain-insights/2025-11-18T17:56:18+08:00https://dengyuemed.com/unlocking-china-pharmacy-wholesale-new-blue-ocean-the-ultimate-guide-to-online-procurement-in-2025/2025-10-27T10:41:52+08:00https://dengyuemed.com/china-pharmacy-wholesale-suppliers-in-2025/2025-11-15T17:05:04+08:00https://dengyuemed.com/innovative-drugs-list-2025-in-china%e4%b8%a8insights-into-the-china-drug-market-and-the-rise-of-drugs-made-in-china/2025-11-18T16:22:26+08:00https://dengyuemed.com/drug-wholesalers-in-china-connecting-the-top-10-chinese-pharmaceutical-companies-to-global-markets/2025-10-28T14:51:10+08:00https://dengyuemed.com/china-pharmaceutical-distributor-redefining-the-future-of-healthcare-supply-chain/2025-11-18T18:02:51+08:00https://dengyuemed.com/the-pharmaceutical-distribution-ecosystem-a-primer-for-china-licensed-wholesale-dealers/2025-10-29T15:23:49+08:00https://dengyuemed.com/pharmaceutical-distributors-in-china%e4%b8%a8the-strategic-force-behind-the-global-expansion-of-in/2025-10-29T17:15:25+08:00https://dengyuemed.com/why-green-strategy-is-the-new-growth-engine-for-china-drug-wholesale-distributors/2025-10-30T14:55:55+08:00https://dengyuemed.com/china-medicine-wholesale-distributor-leads-global-expansion-via-the-belt-and-road-initiative/2025-10-30T16:50:26+08:00https://dengyuemed.com/chinese-biotech-soars-innovents-11-4b-takeda-deal-leads-historic-global-breakthrough/2025-10-31T14:38:03+08:00https://dengyuemed.com/from-quantity-to-quality-chinas-pharmaceutical-innovation-enters-a-golden-decade/2025-10-31T17:54:18+08:00https://dengyuemed.com/fda-innovative-drugs-2025-rare-disease-treatments-antibody-advances-and-expedited-reviews-define-the-year/2025-11-01T14:34:34+08:00https://dengyuemed.com/ai-in-innovative-drug-development-a-new-turning-point-in-the-global-pharmaceutical-industry/2025-11-01T16:51:29+08:00https://dengyuemed.com/zeprumetostat-ezh2-inhibitor-approved-by-nmpa-hengrui-pharma-advances-r-r-ptcl-treatment-innovation/2025-11-03T17:43:39+08:00https://dengyuemed.com/ifupinostat-hydrochloride-novel-r-r-dlbcl/2025-11-05T09:17:51+08:00https://dengyuemed.com/lisaftoclax-tablets-the-first-domestic-bcl-2-inhibitor-approved-for-cll-sll-treatment-in-china/2025-11-05T17:30:05+08:00https://dengyuemed.com/sebaloxavir-marboxil-tablets-approved-by-nmpa-opening-a-new-era-of-single-dose-long-lasting-protection-against-influenza/2025-11-06T17:16:00+08:00https://dengyuemed.com/verify-authenticity-of-chinese-medicines-a-professional-guide-from-a-pharmaceutical-wholesaler/2025-11-10T10:20:04+08:00https://dengyuemed.com/how-china-ensures-the-quality-and-safety-of-its-exported-pharmaceuticals/2025-11-18T17:50:21+08:00https://dengyuemed.com/firsekibart-injection-approved-by-nmpa-a-breakthrough-il-1%ce%b2-antibody-offering-long-acting-relief-for-acute-gouty-arthritis/2025-11-12T09:15:12+08:00https://dengyuemed.com/global-first-dual-target-covid-19-drug-olgotrelvir-sodium-capsules-approved-by-chinas-nmpa/2025-11-12T16:03:50+08:00https://dengyuemed.com/suvemcitug-injection-approval-in-china%e4%b8%a8brings-a-new-treatment-option-for-platinum-resistant-ovarian-cancer/2025-11-13T09:58:35+08:00https://dengyuemed.com/onradivir-tablets-officially-approved-by-nmpa%e4%b8%a8marking-a-major-breakthrough-in-influenza-treatment/2025-11-13T17:08:32+08:00https://dengyuemed.com/chinas-first-homegrown-adc-for-her2-mutant-nsclc-approved-trastuzumab-rezetecan-injection-officially-launched/2025-11-17T16:32:34+08:00https://dengyuemed.com/top-100-pharma-exporters-in-china-how-china-became-a-global-pharmaceutical-powerhouse/2025-11-19T17:12:48+08:00https://dengyuemed.com/top-medicine-exporters-in-china%e4%b8%a8dengyue-medicine/2025-11-19T18:04:48+08:00https://dengyuemed.com/key-benefits-of-partnering-with-leading-pharmaceutical-wholesalers-in-china/2025-11-20T17:31:37+08:00https://dengyuemed.com/china-approves-inpegsomatropin-injection-for-children-with-growth-hormone-deficiency/2025-11-21T16:36:18+08:00https://dengyuemed.com/zanidatamab-injection-ziihera-approved-in-china-for-her2-positive-advanced-biliary-tract-cancer/2025-11-24T18:03:31+08:00https://dengyuemed.com/how-to-import-medicines-from-china-a-complete-2025-guide-for-global-pharmaceutical-buyers/2025-11-25T18:01:13+08:00https://dengyuemed.com/china-pharma-distribution-trends-2025-key-insights-and-predictions/2025-11-27T09:37:47+08:00https://dengyuemed.com/how-strong-is-china-innovative-drug-industry-china-emerges-as-a-global-pharma-innovation-powerhouse/2025-11-27T17:59:32+08:00https://dengyuemed.com/what-is-innovative-drug-exploring-the-future-of-medicine/2025-11-29T17:42:08+08:00https://dengyuemed.com/fosrolapitant-and-palonosetron-hydrochloride-for-injection/2025-12-04T15:29:45+08:00https://dengyuemed.com/innovative-drug-delivery-systems-transforming-modern-medicine/2025-12-04T17:00:06+08:00https://dengyuemed.com/nbp-butylphthalide-a-breakthrough-in-neuroprotection-for-ischemic/2025-12-09T11:24:56+08:00https://dengyuemed.com/luvometinib-tablets-approved-in-china-%e4%b8%a8a-next-generation-mek1-2-inhibitor-for-rare-mapk-driven-tumors/2025-12-05T11:14:05+08:00https://dengyuemed.com/why-omega-3-acid-ethyl-esters-matter-a-clinically-tested-solution-for-severe-hypertriglyceridemia/2025-12-05T17:59:53+08:00https://dengyuemed.com/anti-tumor-therapies-key-drugs-and-modern-cancer-treatment-approaches/2025-12-12T17:10:46+08:00https://dengyuemed.com/erlotinib-hydrochloride-tablets-a-foundational-milestone-in-the-era-of-egfr-targeted-therapy/2025-12-11T09:24:44+08:00https://dengyuemed.com/primary-hypertension-treatment-made-simple-what-it-is-and-how-its-managed-today/2025-12-12T17:10:59+08:00https://dengyuemed.com/new-copd-treatment-launched-whats-new-in-2025-and-whats-next-for-global-and-china-copd-care/2025-12-16T10:36:54+08:00https://dengyuemed.com/%e8%87%aa%e5%8a%a8%e8%8d%89%e7%a8%bf/2025-12-13T15:11:33+08:00https://dengyuemed.com/from-generics-to-bio-engineering-how-china-is-redesigning-the-future-of-medicine/2025-12-17T10:30:04+08:00https://dengyuemed.com/2025-in-review%e4%b8%a8dual-harvest-for-china-innovative-drugs-how-rd-leadership-met-capital-validation/2025-12-19T18:07:48+08:00https://dengyuemed.com/combating-the-silent-killer-how-novel-targeted-therapy-is-redefining-primary-iga-nephropathy-treatment-and-altering-the-course-to-kidney-failure/2025-12-19T18:03:54+08:00https://dengyuemed.com/landmark-approval-datopotamab-deruxtecan-approval-in-china-signaling-a-major-shift-in-breast-cancer-treatment-landscape/2025-12-22T17:47:39+08:00https://dengyuemed.com/what-causes-plaque-psoriasis-how-does-the-new-drug-mufemilast-offer-a-novel-treatment-choice/2025-12-23T17:54:58+08:00https://dengyuemed.com/a-breakthrough-in-fatal-pulmonary-fibrosis-worlds-first-pde4b-inhibitor-nerandomilast-approved-in-china/2025-12-26T14:22:50+08:00https://dengyuemed.com/the-iga-nephropathy-new-treatment-revolution-from-supportive-care-to-precision-targeting/2025-12-27T09:15:33+08:00https://dengyuemed.com/telitacicept-mechanism-of-action-a-chinese-innovative-dual-target-breakout/2025-12-27T09:13:50+08:00https://dengyuemed.com/from-a-regional-mystery-to-a-global-breakthrough-the-scientific-journey-of-nasopharyngeal-carcinoma-treatment/2025-12-29T15:02:34+08:00https://dengyuemed.com/new-hope-for-advanced-nasopharyngeal-carcinoma-becotatug-vedotin-receives-regulatory-approval/2025-12-29T14:47:55+08:00https://dengyuemed.com/domestic-met-inhibitor-glumetinib-approval-bringing-high-response-rates-to-specific-lung-cancer-patients/2025-12-31T17:50:58+08:00https://dengyuemed.com/how-everolimus-works-precision-targeting-of-tumor-growth-pathways/2025-12-31T18:02:12+08:00https://dengyuemed.com/what-sets-saibeixin-pazopanib-tablets-apart/2026-01-05T16:41:59+08:00https://dengyuemed.com/how-ramucirumab-works-precision-targeting-of-tumour-angiogenesis/2026-01-07T11:38:10+08:00https://dengyuemed.com/precision-strike-new-breakthrough-chinas-original-high-selectivity-btk-inhibitor-orelabrutinib-innocare-approval/2026-01-05T16:32:06+08:00https://dengyuemed.com/how-did-fruquintinib-elunate-become-the-key-breakthrough-in-the-treatment-of-advanced-colorectal-cancer/2026-01-06T17:55:49+08:00https://dengyuemed.com/when-should-you-take-avatrombopag-maleate-qinganxin-precision-solutions-for-the-platelet-crisis/2026-01-14T16:53:00+08:00https://dengyuemed.com/good-news-for-cll-sll-sonrotoclax-approved-in-china/2026-01-08T17:32:57+08:00https://dengyuemed.com/tpiao-approved-for-a-new-indication-clinical-progress-of-recombinant-human-thrombopoietin-in-the-treatment-of-thrombocytopenia/2026-01-09T14:29:53+08:00https://dengyuemed.com/biktarvy-how-does-a-three-drug-in-one-regimen-define-the-gold-standard-in-hiv-treatment/2026-01-12T14:37:47+08:00https://dengyuemed.com/how-ripretinib-has-reshaped-the-treatment-landscape-of-advanced-gist/2026-01-14T10:27:27+08:00https://dengyuemed.com/unlocking-treatment-chidamide-for-lymphoma-and-breast-cancer/2026-01-15T16:39:10+08:00https://dengyuemed.com/which-11-drugs-will-define-the-future-of-pharma-in-2026/2026-01-19T10:47:57+08:00https://dengyuemed.com/what-are-tenofovir-tablets-used-for-understanding-their-indications-in-hepatitis-b/2026-01-20T09:27:58+08:00https://dengyuemed.com/what-is-the-mechanism-of-action-of-navelbine/2026-01-27T09:34:15+08:00https://dengyuemed.com/what-riociguat-is-used-for/2026-01-26T09:43:58+08:00https://dengyuemed.com/what-is-the-mechanism-of-action-of-dalpiciclib-airuikang/2026-01-27T09:42:07+08:00https://dengyuemed.com/a-comprehensive-guide-to-ariane-a-new-drug-for-prostate-cancer-what-is-the-mechanism-of-action-of-rezvilutamide/2026-01-29T10:15:15+08:00https://dengyuemed.com/2026-lung-cancer-treatment-guide-21-newly-approved-drugs-and-6-breakthrough-immunotherapies-targeting-eight-key-pathways/2026-01-31T10:20:53+08:00https://dengyuemed.com/what-is-megestrol-acetate-oral-suspension-improving-appetite-and-weight/2026-02-03T10:16:08+08:00https://dengyuemed.com/the-role-of-pharmaceutical-wholesalers-with-drugmakers/2026-01-26T09:54:29+08:00https://dengyuemed.com/secukinumab-injection-uses-explained-why-il-17a-inhibition-is-reshaping-treatment-for-psoriasis-and-inflammatory-arthritis/2026-02-07T11:58:26+08:00https://dengyuemed.com/darzalex-faspro-or-darzalex-whats-the-difference-between-two-forms-of-daratumumab/2026-02-07T11:59:22+08:00https://dengyuemed.com/adebrelimab-approval-in-china-the-first-domestic-pd-l1-antibody-for-small-cell-lung-cancer/2026-02-07T12:00:23+08:00https://dengyuemed.com/what-is-taltz-ixekizumab-used-for-a-precision-biologic-that-targets-il-17a-driven-inflammation/2026-02-04T09:43:52+08:00https://dengyuemed.com/what-is-ponatinib-used-for-targeting-t315i-mutant-cml-and-ph-all/2026-02-07T12:02:02+08:00https://dengyuemed.com/what-class-of-drug-is-penpulimab-how-this-fc-engineered-pd-1-monoclonal-antibody-restores-anti-tumor-immunity/2026-02-13T14:52:57+08:00https://dengyuemed.com/what-is-olaparib-used-for-a-parp-inhibitor-targeting-dna-repair-defects-in-cancer/2026-02-09T11:06:29+08:00https://dengyuemed.com/from-first-to-third-generation-egfr-targeted-drugs/2026-07-14T11:13:16+08:00https://dengyuemed.com/alk-inhibitors-for-lung-cancer/2026-07-16T14:08:23+08:00https://dengyuemed.com/complete-lung-cancer-drugs-list-2026-update/2026-07-17T14:28:44+08:00https://dengyuemed.com/pimicotinib-for-tenosynovial-giant-cell-tumor/2026-07-11T11:29:49+08:00https://dengyuemed.com/top-5-rare-disease-companies/2026-07-09T15:28:22+08:00https://dengyuemed.com/reputable-pharmaceutical-wholesaler/2026-02-25T11:51:45+08:00https://dengyuemed.com/drug-treatment-of-duchenne-muscular-dystrophy/2026-07-11T11:36:39+08:00https://dengyuemed.com/pharmaceutical-distributor-in-hong-kong/2026-07-14T10:40:49+08:00https://dengyuemed.com/china-pharmaceutical-wholesaler/2026-03-24T12:00:18+08:00https://dengyuemed.com/nmpa-approved-drugs-list-february-2026-3-innovative-drugs-approved-in-china/2026-03-05T10:38:29+08:00https://dengyuemed.com/11-new-cancer-drugs-approved/2026-07-17T14:46:43+08:00https://dengyuemed.com/colorectal-cancer-treatment-options-in-china/2026-03-17T09:27:01+08:00https://dengyuemed.com/what-are-the-8-signs-of-liver-cancer-getting-worse/2026-06-26T17:28:48+08:00https://dengyuemed.com/china-generic-drug-market-2026/2026-03-16T18:25:07+08:00https://dengyuemed.com/adc-drugs-by-target-in-2026/2026-03-25T11:44:05+08:00https://dengyuemed.com/latest-advances-in-thalassemia-gene-therapy-how-crispr-and-gene-addition-therapies-enable-tdt-patients-to-become-transfusion-independent/2026-07-22T14:12:56+08:00https://dengyuemed.com/abbisko-therapeutics-absk061-receives-fda-orphan-drug-designation-advancing-targeted-therapy-for-achondroplasia/2026-03-20T15:45:11+08:00https://dengyuemed.com/global-advantages-of-china-pharmaceuticals-how-four-core-capabilities-improve-drug-accessibility/2026-03-24T11:13:07+08:00https://dengyuemed.com/china-pharmaceutical-procurement-process-guide-rfq-compliance-payment-global-delivery/2026-03-26T10:44:42+08:00https://dengyuemed.com/africas-pharmaceutical-challenges-analysis-of-supply-structure-and-drug-access/2026-03-28T12:33:16+08:00https://dengyuemed.com/nmpa-approves-gsk-depemokimab-in-china-for-severe-eosinophilic-asthma-with-twice-yearly-dosing/2026-03-31T14:05:40+08:00https://dengyuemed.com/cell-therapy-vs-gene-therapy-in-china-key-differences-and-approved-cgt-drugs/2026-04-03T10:52:25+08:00https://dengyuemed.com/bispecific-adc-development-in-breast-cancer-emerging-targets-and-clinical-progress/2026-04-03T14:45:25+08:00https://dengyuemed.com/china-pharmaceutical-export-trends-and-global-pharmaceutical-market-opportunities/2026-04-10T11:48:14+08:00https://dengyuemed.com/what-are-the-top-5-autoimmune-diseases-to-watch-in-2026-insights-into-immunotherapy-trends-and-innovation/2026-04-11T14:49:24+08:00https://dengyuemed.com/hcc-first-and-second-line-treatment-updates/2026-06-18T16:08:59+08:00https://dengyuemed.com/sevabertinib-approved-in-china-for-her2-mutant-nsclc/2026-04-16T15:25:21+08:00https://dengyuemed.com/top-5-global-neuroscience-pharma-companies/2026-04-17T14:52:12+08:00https://dengyuemed.com/belantamab-mafodotin-approved-in-china-for-multiple-myeloma/2026-04-21T11:29:03+08:00https://dengyuemed.com/approved-immune-checkpoint-inhibitors-in-china/2026-04-23T15:12:23+08:00https://dengyuemed.com/rna-based-therapeutic-approaches-for-cardiovascular-disease/2026-06-24T16:08:19+08:00https://dengyuemed.com/china-approves-first-generic-upadacitinib/2026-05-08T15:11:15+08:00https://dengyuemed.com/drug-shortages-by-country/2026-04-30T16:25:16+08:00https://dengyuemed.com/china-innovative-drug-approvals-april-2026/2026-05-07T11:21:32+08:00https://dengyuemed.com/2026-gastric-cancer-treatment-drug-guide/2026-05-08T14:31:48+08:00https://dengyuemed.com/top-10-hospitals-in-china-for-international-patients/2026-05-12T15:26:11+08:00https://dengyuemed.com/cancer-treatment-in-china-for-international-patients/2026-05-13T16:47:54+08:00https://dengyuemed.com/modern-cancer-treatment-in-china/2026-05-15T14:31:28+08:00https://dengyuemed.com/epcoritamab-approved-in-china-for-follicular-lymphoma/2026-05-19T14:42:21+08:00https://dengyuemed.com/advances-in-spinal-muscular-atrophy/2026-05-20T16:45:09+08:00https://dengyuemed.com/pharmaceutical-transportation-requirements/2026-05-21T16:32:37+08:00https://dengyuemed.com/nipocalimab-approved-in-china-for-generalized-myasthenia-gravis/2026-05-27T10:29:41+08:00https://dengyuemed.com/china-peptide-api-company-landscape/2026-05-28T11:37:19+08:00https://dengyuemed.com/causes-of-the-global-counterfeit-drug-problem/2026-05-29T14:04:36+08:00https://dengyuemed.com/which-cancers-does-china-have-advantages-in/2026-06-02T11:47:09+08:00https://dengyuemed.com/may-2026-china-innovative-drug-approvals/2026-06-03T14:25:10+08:00https://dengyuemed.com/access-pathways-for-innovative-medicines-in-china/2026-06-04T15:50:56+08:00https://dengyuemed.com/new-hemophilia-drug-approved-in-china/2026-06-05T15:21:13+08:00https://dengyuemed.com/10-common-questions-cancer-patients-ask/2026-06-23T17:30:52+08:00https://dengyuemed.com/gumokimab-approved-for-plaque-psoriasis/2026-06-16T14:48:35+08:00https://dengyuemed.com/china-pharmaceutical-raw-materials/2026-06-18T15:00:21+08:00https://dengyuemed.com/cfb-inhibitor-lanoracopan-approved-by-nmpa/2026-06-16T14:31:45+08:00https://dengyuemed.com/what-are-degrader-antibody-conjugates/2026-06-17T17:09:16+08:00https://dengyuemed.com/how-to-find-generic-drug-versions-in-china/2026-06-18T15:59:54+08:00https://dengyuemed.com/izalontamab-brengitecan-approved-in-china/2026-07-21T15:17:16+08:00https://dengyuemed.com/china-approves-the-worlds-first-car-t-therapy-for-solid-tumors/2026-07-30T14:49:52+08:00https://dengyuemed.com/silevimig-approved-for-rabies-passive-immunization/2026-06-26T10:51:03+08:00https://dengyuemed.com/eli-lillys-imlunestrant-approved-in-china/2026-06-27T10:15:34+08:00https://dengyuemed.com/antimicrobial-peptides-against-antibiotic-resistance/2026-07-29T15:56:33+08:00https://dengyuemed.com/how-do-pharmaceutical-wholesalers-work/2026-07-08T14:26:09+08:00https://dengyuemed.com/how-to-find-the-latest-breast-cancer-drugs/2026-07-10T10:13:50+08:00https://dengyuemed.com/china-national-essential-medicines-list-2026/2026-07-11T09:54:23+08:00https://dengyuemed.com/what-ovarian-cancer-drugs-are-available-in-china/2026-07-15T11:01:14+08:00https://dengyuemed.com/octahydroaminoacridine-succinate-approved-in-china/2026-07-16T09:47:46+08:00https://dengyuemed.com/adamgammadex-sodium-approved-by-nmpa-the-worlds-second-and-chinas-first-homegrown-targeted-neuromuscular-block-reversal-agent/2026-07-17T11:58:47+08:00https://dengyuemed.com/the-first-approved-adc-for-esophageal-squamous-cell-carcinoma/2026-07-21T17:50:30+08:00https://dengyuemed.com/oveporexton-approved-first-in-china/2026-07-27T14:30:10+08:00https://dengyuemed.com/ciprocopan-approved-in-china/2026-07-27T14:31:51+08:00https://dengyuemed.com/plozasiran-now-available-in-china/2026-07-28T11:54:20+08:00https://dengyuemed.com/common-drugs-for-prostate-cancer/2026-07-29T15:43:43+08:00https://dengyuemed.com/recibokibart-approved-for-gpp/2026-08-04T17:27:12+08:00https://dengyuemed.com/what-are-the-most-common-chemotherapy-drugs/2026-08-06T15:40:15+08:00https://dengyuemed.com/how-to-identify-the-early-signs-of-melanoma/2026-08-10T15:53:33+08:00https://dengyuemed.com/breast-cancer-drug-list-in-china/2026-08-12T11:40:11+08:00https://dengyuemed.com/tinengotinib-approved-for-cholangiocarcinoma/2026-08-14T10:44:10+08:00https://dengyuemed.com/felzartamab-approved-for-multiple-myeloma/2026-08-14T15:57:32+08:00